| 产品名称： | Clonostachys compactiuscula (Saccardo) Hawksworth et Gams, anamorph |
|---|---|
| 商品货号： | TS164628 |
| Strain Designations： | 38009 |
| Application： | hydrolyzes lovastatin produces triol acid Hydrolysis of lovastatin to triol acid |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 324: Malt extract agar |
| Growth Conditions： | Temperature: 24.0°C |
| Sequenced Data： | xa0xa0No DNA sequencing was performed in house on this strain. |
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Isolation： | Redeposit of ATCC 38009 for patent purposes |
| References： | Conder M, et al. Biosynthetic production of 7-(1,26,7,888A(R)-hexahydro-2(S),6(R)-dimethyl-8(S)-hydroxy-1(S)-naphthyl-3(R),5(R)-dihydroxyheptanoic acid (triol acid). US Patent 5,223,415 dated Jun 29 1993 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Clonostachys compactiuscula (Saccardo) Hawksworth et Gams, anamorph |
|---|---|
| 商品货号： | TS164628 |
| Strain Designations： | 38009 |
| Application： | hydrolyzes lovastatin produces triol acid Hydrolysis of lovastatin to triol acid |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 324: Malt extract agar |
| Growth Conditions： | Temperature: 24.0°C |
| Sequenced Data： | xa0xa0No DNA sequencing was performed in house on this strain. |
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Isolation： | Redeposit of ATCC 38009 for patent purposes |
| References： | Conder M, et al. Biosynthetic production of 7-(1,26,7,888A(R)-hexahydro-2(S),6(R)-dimethyl-8(S)-hydroxy-1(S)-naphthyl-3(R),5(R)-dihydroxyheptanoic acid (triol acid). US Patent 5,223,415 dated Jun 29 1993 |
